Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Forecast & Target Price

View the latest analyst price targets and forecasts to stay informed on market expectations. Click here to open.

PRCT

Procept BioRobotics Corp

Nov 27 • 04:00PM ET

97.29

Dollar change -1.98
Percentage change -1.99	%

Healthcare • Medical Devices • USA • NASD

Peers: ISRG MDT ABT SYK BSX EW COO ZBH TFX PODD

| Held by: VTI IWM VB VXF VBK BOTZ IWO IHI SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.95	Insider Own	5.56%	Shs Outstand	54.39M	Perf Week	4.95%
Market Cap	5.19B	Forward P/E	-	EPS next Y	-1.32	Insider Trans	-19.86%	Shs Float	51.37M	Perf Month	0.62%
Income	-100.06M	PEG	-	EPS next Q	-0.33	Inst Own	84.37%	Short Float	12.40%	Perf Quarter	23.64%
Sales	199.84M	P/S	25.95	EPS this Y	22.65%	Inst Trans	1.55%	Short Ratio	7.81	Perf Half Y	51.49%
Book/sh	4.63	P/B	21.03	EPS next Y	24.07%	ROA	-25.16%	Short Interest	6.37M	Perf Year	188.10%
Cash/sh	3.69	P/C	26.36	EPS next 5Y	26.50%	ROE	-37.02%	52W Range	33.45 - 103.81	Perf YTD	132.14%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.27%	ROI	-31.27%	52W High	-6.28%	Beta	1.01
Dividend TTM	-	Quick Ratio	5.07	Sales past 5Y	142.74%	Gross Margin	54.83%	52W Low	190.85%	ATR (14)	4.53
Dividend Ex-Date	-	Current Ratio	6.02	EPS Y/Y TTM	16.25%	Oper. Margin	-53.27%	RSI (14)	60.14	Volatility	3.78% 5.20%
Employees	626	Debt/Eq	0.33	Sales Y/Y TTM	71.71%	Profit Margin	-50.07%	Recom	1.44	Target Price	102.14
Option/Short	Yes / Yes	LT Debt/Eq	0.33	EPS Q/Q	20.88%	Payout	-	Rel Volume	0.64	Prev Close	99.27
Sales Surprise	9.50%	EPS Surprise	18.13%	Sales Q/Q	66.29%	Earnings	Oct 28 BMO	Avg Volume	815.68K	Price	97.29
SMA20	3.06%	SMA50	16.65%	SMA200	46.00%	Trades		Volume	519,410	Change	-1.99%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-14-24	Initiated	Jefferies	Hold	$95
Aug-11-23	Initiated	Piper Sandler	Overweight	$42
May-31-23	Initiated	William Blair	Outperform
Oct-31-22	Initiated	BTIG Research	Neutral
Oct-25-22	Initiated	Truist	Buy	$58
Sep-02-22	Initiated	Wells Fargo	Overweight	$49
Jul-15-22	Initiated	KeyBanc Capital Markets	Overweight	$47
Jun-23-22	Initiated	B. Riley Securities	Buy	$53
Oct-11-21	Initiated	SVB Leerink	Outperform	$46
Oct-11-21	Initiated	Guggenheim	Buy	$45
Oct-11-21	Initiated	Goldman	Neutral	$37
Oct-11-21	Initiated	Cowen	Outperform	$50
Oct-11-21	Initiated	BofA Securities	Buy	$48

Show Previous Ratings

Nov-26-24 04:05PM	PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024 (GlobeNewswire)
Nov-07-24 12:00PM	Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice (Zacks)
Nov-01-24 02:27PM	These IBD 50 Leaders Melt Gains As Stock Market Wavers (Investor's Business Daily)
Oct-29-24 08:43PM	PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock (GlobeNewswire) +6.25%
12:00PM	All You Need to Know About PROCEPT BioRobotics (PRCT) Rating Upgrade to Strong Buy (Zacks)
11:56AM	Loading…
11:56AM	Medical Gear Stock Surges Past Buy Point On Upbeat Sales Outlook (Investor's Business Daily)
03:03AM	PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Oct-28-24 05:41PM	Procept BioRobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise (Investor's Business Daily) +32.33%
04:19PM	PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock (GlobeNewswire)
02:17PM	Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential (Benzinga)
11:39AM	PROCEPT BioRobotics Jumps 30% Today on Massive Revenue Surge (GuruFocus.com)
08:10AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance (GlobeNewswire)
07:00AM	Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner (PR Newswire)
Oct-25-24 09:35AM	Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT) Looks Ripe for a Turnaround (Zacks)
09:01AM	Loading…
09:01AM	Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Reports Q3 2024 Result (GuruFocus.com)
Oct-21-24 10:00AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-09-24 04:04PM	PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024 (GlobeNewswire)
Oct-08-24 12:29PM	PROCEPT BioRobotics wins FDA IDE for aquablation trial in prostate cancer (Medical Device Network) +6.29%
Oct-07-24 04:04PM	PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer (GlobeNewswire)
Oct-05-24 06:04PM	PROCEPT BioRobotics Corporation (PRCT) Advances Urology with AI-Integrated HYDROS Robotic System; Price Target Raised to $99 (Insider Monkey)
Sep-25-24 09:01AM	Is Procept Biorobotics Corp. (PRCT) the Worst AI Stock to Buy? (Insider Monkey)
Sep-23-24 09:03AM	Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator? (Insider Monkey) -5.60%
Aug-30-24 05:57AM	Do You Believe in the Growth Prospects of PROCEPT BioRobotics (PRCT)? (Insider Monkey)
Aug-28-24 04:03PM	PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 (GlobeNewswire)
Aug-22-24 01:05PM	PROCEPT BioRobotics' (PRCT) HYDROS System Gets FDA Clearance (Zacks)
09:12AM	PROCEPT (PRCT) Grows in Urology With FDA Clearance for HYDROS (Zacks)
Aug-21-24 07:00AM	PROCEPT BioRobotics Announces FDA Clearance of the HYDROS Robotic System, the Next-Generation, AI-Powered Platform for Aquablation Therapy (GlobeNewswire) +28.36%
Aug-14-24 04:30PM	3 Robotics Stocks to Sell in August Before They Crash & Burn (InvestorPlace)
Aug-01-24 05:50PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -7.45%
04:03PM	Loading…
04:03PM	PROCEPT BioRobotics Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance (GlobeNewswire)
Jul-15-24 04:03PM	PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024 (GlobeNewswire)
Jun-27-24 04:38PM	You've Been Warned! 3 Robotics Stocks to Buy Now or Regret Forever. (InvestorPlace)
Jun-19-24 02:40AM	Insider Selling: EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics ... (GuruFocus.com)
Jun-17-24 04:03PM	PROCEPT BioRobotics Announces New CPT Category I Code from the American Medical Association for Aquablation therapy (GlobeNewswire)
Jun-03-24 04:03PM	PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024 (GlobeNewswire)
May-17-24 05:20PM	Intuitive Surgical, IBD Stock Of The Day, Feels Its Way Toward Buy Point (Investor's Business Daily)
May-14-24 06:00AM	From Science Fiction to Reality: 3 Robotics Stocks for Automatic Riches (InvestorPlace)
May-13-24 04:05PM	PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference (GlobeNewswire)
May-06-24 09:40AM	Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating (MT Newswires)
08:00AM	Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia (GlobeNewswire)
03:08AM	Procept BioRobotics Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing (MT Newswires)
May-04-24 02:58AM	Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
May-03-24 04:00PM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 08:15AM	Truist Raises PROCEPT BioRobotics' PT to $72 From $63 After 'Solid' Q1 Beat, Keeps Buy Rating (MT Newswires)
May-01-24 03:59PM	Biotech Leader Procept BioRobotics Surges Past Buy Point On Earnings (Investor's Business Daily) +14.40%
01:53PM	PRCT Stock Earnings: PROCEPT BioRobotics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
12:13PM	Procept BioRobotics Shares Rise After Q1 Loss Narrows, Revenue Increases; 2024 Revenue Guidance Revised (MT Newswires)
08:25AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (GlobeNewswire)
Apr-29-24 08:00AM	Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia (GlobeNewswire)
Apr-23-24 08:00AM	PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting (GlobeNewswire) +5.00%
Apr-04-24 04:04PM	PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas (GlobeNewswire)
Apr-02-24 04:03PM	PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024 (GlobeNewswire)
Mar-20-24 07:01PM	PROCEPT BioRobotics Corp (PRCT) President and CEO Reza Zadno Sells Company Shares (GuruFocus.com)
Mar-08-24 01:30AM	EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Mar-06-24 11:55PM	Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Feb-28-24 12:00PM	Q4 2023 Procept Biorobotics Corp Earnings Call (Thomson Reuters StreetEvents)
10:00AM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 04:02PM	PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-20-24 10:00AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-12-24 04:05PM	PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston (GlobeNewswire)
Feb-10-24 02:07AM	EVP, CLO, CORP. SEC. Alaleh Nouri Sells 20,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Feb-08-24 05:30PM	CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors (GlobeNewswire)
Jan-11-24 11:02PM	EVP, CLO, CORP. SEC. Alaleh Nouri Sells 16,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Jan-10-24 03:51AM	Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength? (Zacks)
Jan-08-24 05:00PM	PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million (GlobeNewswire) +15.14%
Dec-16-23 07:02AM	Insider Sell Alert: EVP Alaleh Nouri Divests 15,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Dec-10-23 01:15AM	Insider Sell Alert: Director Frederic Moll Sells 79,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Dec-09-23 01:05AM	EVP, CFO Kevin Waters Sells 15,085 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Dec-05-23 02:44PM	PROCEPT BioRobotics Stock Scores Rising Relative Strength (Investor's Business Daily)
Nov-15-23 01:03AM	Insider Sell Alert: Director Morgan Wood Sells 25,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Nov-13-23 04:03PM	PROCEPT BioRobotics to Present at the 35 Annual Piper Sandler Healthcare Conference in New York City (GlobeNewswire)
Nov-06-23 09:55AM	Wall Street Analysts Predict a 25.54% Upside in PROCEPT BioRobotics Corporation (PRCT): Here's What You Should Know (Zacks)
Nov-02-23 04:07PM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2023 Earnings Call Transcript (Insider Monkey) +18.37%
09:33AM	Q3 2023 PROCEPT BioRobotics Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 04:02PM	PROCEPT BioRobotics Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance (GlobeNewswire)
Oct-25-23 10:02AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-16-23 04:05PM	PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023 (GlobeNewswire) +9.58%
10:23AM	Wayfair upgraded, JD.com downgraded: Wall Street's top analyst calls (The Fly)
08:43AM	Tandem Diabetes Care, Inc. (TNDM) Soars 6.0%: Is Further Upside Left in the Stock? (Zacks)
Oct-12-23 08:00AM	The National Institute for Health and Care Excellence Endorses Aquablation Therapy with 'Standard Arrangements' Recommendation (GlobeNewswire)
Sep-20-23 08:00AM	PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose (GlobeNewswire)
Sep-12-23 08:00AM	PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer (GlobeNewswire)
Aug-22-23 08:00AM	PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan (GlobeNewswire)
Aug-17-23 04:05PM	PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston (GlobeNewswire)
Aug-16-23 08:00AM	NorthShore University HealthSystem offers expanded access to treat most common prostate ailment (GlobeNewswire)
Aug-11-23 09:36AM	Twilio upgraded, Sealed Air downgraded: Wall Street's top analyst calls (The Fly)
Aug-02-23 07:14AM	The one-year earnings decline has likely contributed toPROCEPT BioRobotics' (NASDAQ:PRCT) shareholders losses of 14% over that period (Simply Wall St.) +6.13%
Aug-01-23 10:10PM	PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock (GlobeNewswire)
04:06PM	PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock (GlobeNewswire)
Jul-27-23 08:35AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -7.14%
07:00AM	PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance (GlobeNewswire)
Jul-11-23 04:03PM	PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023 (GlobeNewswire) -6.42%
May-17-23 06:12AM	Positive week for PROCEPT BioRobotics Corporation (NASDAQ:PRCT) institutional investors who lost 17% over the past year (Simply Wall St.)
May-14-23 02:57PM	7 Growth Stocks That Could Double Your Money in 2023 (InvestorPlace)
Apr-28-23 08:00AM	Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates (GlobeNewswire) +13.82%
Apr-27-23 12:52PM	Why Shares of Procept Biorobotics Were Slumping Thursday (Motley Fool) -25.31%
08:25AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance (GlobeNewswire)

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
REZA ZADNO	Director	Nov 27 '24	Proposed Sale	99.27	26,420	2,622,713		Nov 27 04:35 PM
Zadno Reza	President, CEO	Nov 20 '24	Sale	92.57	26,420	2,445,724	205,605	Nov 22 04:07 PM
REZA ZADNO	Director	Nov 20 '24	Proposed Sale	93.57	26,420	2,472,119		Nov 20 04:29 PM
Zadno Reza	President, CEO	Nov 13 '24	Sale	94.08	26,420	2,485,573	232,025	Nov 15 04:28 PM
REZA ZADNO	Director	Nov 13 '24	Proposed Sale	95.55	26,420	2,524,431		Nov 13 04:23 PM
Desai Antal Rohit	Director	Nov 07 '24	Sale	95.39	34,000	3,243,158	164,363	Nov 07 08:05 PM
Desai Antal Rohit	Director	Nov 06 '24	Sale	97.04	33,000	3,202,444	198,363	Nov 07 08:05 PM
Desai Antal Rohit	Director	Nov 05 '24	Sale	96.60	33,000	3,187,835	231,363	Nov 07 08:05 PM
222 DNA TRUST	Director	Nov 05 '24	Proposed Sale	97.07	100,000	9,707,000		Nov 05 04:23 PM
Zadno Reza	President, CEO	Oct 30 '24	Option Exercise	4.37	288,461	1,260,575	546,906	Oct 31 05:07 PM
Zadno Reza	President, CEO	Oct 30 '24	Sale	91.00	288,461	26,249,951	258,445	Oct 31 05:07 PM
Waters Kevin	EVP, CFO	Oct 15 '24	Option Exercise	4.56	25,000	114,000	121,096	Oct 17 04:27 PM
Waters Kevin	EVP, CFO	Oct 15 '24	Sale	72.47	25,000	1,811,653	96,096	Oct 17 04:27 PM
Waters Kevin	EVP, CFO	Sep 16 '24	Option Exercise	4.53	25,000	113,363	121,096	Sep 18 05:59 PM
Waters Kevin	EVP, CFO	Sep 16 '24	Sale	82.51	25,000	2,062,679	96,096	Sep 18 05:59 PM
Kevin Waters	Affiliate	Sep 16 '24	Proposed Sale	81.11	50,000	4,055,500		Sep 16 05:47 PM
Desai Antal Rohit	Director	Sep 12 '24	Sale	80.11	44,867	3,594,377	197,453	Sep 12 08:03 PM
Desai Antal Rohit	Director	Sep 11 '24	Sale	77.54	38,698	3,000,648	242,320	Sep 12 08:03 PM
Desai Antal Rohit	Director	Sep 10 '24	Sale	76.18	36,500	2,780,570	281,018	Sep 12 08:03 PM
Desai Antal Rohit	Director	Sep 04 '24	Sale	75.42	36,212	2,731,122	330,823	Sep 05 07:13 PM
Desai Antal Rohit	Director	Sep 03 '24	Sale	76.12	35,220	2,680,811	23,963	Sep 05 07:13 PM
Desai Antal Rohit	Director	Sep 04 '24	Sale	75.42	17,420	1,313,876	6,543	Sep 05 07:13 PM
Desai Antal Rohit	Director	Sep 05 '24	Sale	76.37	13,305	1,016,085	317,518	Sep 05 07:13 PM
222 DNA TRUST	Director	Sep 04 '24	Proposed Sale	75.06	169,582	12,728,825		Sep 04 04:16 PM
ANTAL ROHIT DESAI	Director	Sep 03 '24	Proposed Sale	79.00	52,640	4,158,560		Sep 03 04:21 PM
Zadno Reza	President, CEO	Jul 31 '24	Option Exercise	4.37	23,484	102,625	258,445	Aug 23 04:19 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jun 17 '24	Sale	62.18	10,000	621,764	52,472	Jun 18 05:32 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Jun 10 '24	Option Exercise	4.56	26,046	118,770	81,906	Jun 12 06:44 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Jun 10 '24	Sale	68.24	26,046	1,777,499	55,860	Jun 12 06:44 PM
Harris Taylor C.	Director	Jun 04 '24	Option Exercise	5.18	81,550	422,429	131,336	Jun 06 04:32 PM
Krummel Thomas M	Director	May 01 '24	Sale	60.00	20,000	1,200,000	45,631	May 03 09:41 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	May 03 '24	Option Exercise	6.87	30,432	208,978	92,904	May 03 09:40 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	May 03 '24	Sale	62.97	30,432	1,916,428	62,472	May 03 09:40 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 18 '24	Sale	48.83	441	21,534	62,472	Mar 20 04:52 PM
Waters Kevin	EVP, CFO	Mar 18 '24	Sale	48.83	1,024	50,002	102,149	Mar 20 04:48 PM
Zadno Reza	President, CEO	Mar 18 '24	Sale	48.83	5,391	263,243	241,319	Mar 20 04:46 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 18 '24	Sale	48.83	244	11,915	55,860	Mar 20 04:41 PM
Waters Kevin	EVP, CFO	Mar 15 '24	Option Exercise	4.53	53,757	243,692	103,173	Mar 18 06:05 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 06 '24	Sale	46.67	2,749	128,296	62,913	Mar 07 07:53 PM
Waters Kevin	EVP, CFO	Mar 06 '24	Sale	46.67	3,435	160,311	49,416	Mar 07 07:51 PM
Zadno Reza	President, CEO	Mar 06 '24	Sale	46.67	9,179	428,384	246,710	Mar 07 07:50 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 06 '24	Sale	46.67	1,759	82,093	56,104	Mar 07 07:50 PM
Krummel Thomas M	Director	Mar 04 '24	Sale	48.53	20,000	970,643	65,631	Mar 06 04:50 PM
Waters Kevin	EVP, CFO	Feb 12 '24	Option Exercise	4.52	22,349	101,017	55,872	Feb 13 04:37 PM
Waters Kevin	EVP, CFO	Feb 12 '24	Sale	50.16	22,349	1,121,062	33,523	Feb 13 04:37 PM
Waters Kevin	EVP, CFO	Feb 09 '24	Option Exercise	4.52	28,677	129,620	62,200	Feb 09 05:09 PM
Waters Kevin	EVP, CFO	Feb 07 '24	Option Exercise	4.52	904	4,086	34,427	Feb 09 05:09 PM
Waters Kevin	EVP, CFO	Feb 09 '24	Sale	50.09	28,677	1,436,379	33,523	Feb 09 05:09 PM
Waters Kevin	EVP, CFO	Feb 07 '24	Sale	50.00	904	45,200	33,523	Feb 09 05:09 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 09 '24	Option Exercise	5.18	14,694	76,115	62,045	Feb 09 05:02 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 07 '24	Option Exercise	5.18	5,306	27,485	52,657	Feb 09 05:02 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 09 '24	Sale	49.97	14,694	734,314	47,351	Feb 09 05:02 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Feb 07 '24	Sale	49.95	5,306	265,053	47,351	Feb 09 05:02 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jan 09 '24	Option Exercise	4.56	16,000	72,960	63,351	Jan 11 05:12 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Jan 09 '24	Sale	44.97	16,000	719,475	47,351	Jan 11 05:12 PM
Waters Kevin	EVP, CFO	Jan 09 '24	Option Exercise	4.52	17,310	78,241	50,833	Jan 11 05:03 PM
Waters Kevin	EVP, CFO	Jan 09 '24	Sale	45.07	17,310	780,247	33,523	Jan 11 05:03 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 15 '23	Option Exercise	4.56	11,796	53,790	58,729	Dec 15 06:28 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 14 '23	Option Exercise	4.56	3,204	14,610	50,137	Dec 15 06:28 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 15 '23	Sale	42.97	11,796	506,843	46,933	Dec 15 06:28 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 14 '23	Sale	42.95	3,204	137,618	46,933	Dec 15 06:28 PM
Waters Kevin	EVP, CFO	Dec 13 '23	Option Exercise	4.52	71,465	323,022	104,988	Dec 15 06:19 PM
Waters Kevin	EVP, CFO	Dec 13 '23	Sale	40.05	71,465	2,862,216	33,523	Dec 15 06:19 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 06 '23	Option Exercise	4.52	6,096	27,554	53,029	Dec 08 08:05 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 06 '23	Sale	39.96	6,096	243,572	46,933	Dec 08 08:05 PM
Waters Kevin	EVP, CFO	Dec 08 '23	Option Exercise	4.52	6,888	31,134	48,608	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 06 '23	Option Exercise	4.52	4,360	19,707	37,883	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 07 '23	Option Exercise	4.52	3,837	17,343	41,720	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 08 '23	Sale	40.02	6,888	275,640	33,523	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 06 '23	Sale	40.02	4,360	174,493	44,248	Dec 08 05:58 PM
Waters Kevin	EVP, CFO	Dec 07 '23	Sale	40.00	3,837	153,480	40,411	Dec 08 05:58 PM
MOLL FREDERIC H	Director	Dec 06 '23	Sale	38.75	79,000	3,061,355	808,233	Dec 08 05:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRCT

Procept BioRobotics Corp

Upgrade your FINVIZ experience